Scientists Studied 'SuperAgers' For 25 Years And Found That They All Have This 1 Habit In Common Chris Hemsworth, Alzheimer's ...

Vertex Pharmaceuticals chief Reshma Kewalramani said AI could reduce the time spent on drug-approval paperwork from months to ...

One key figure, however, indicates otherwise as sales for Journavx were at $20 million for the period, coming up $3 million ...

Human cognition and AI cognition may never share a full axis. But independence does not imply isolation either. The future may not be convergence at all. The future may be a sort of “co-angulation,” ...

Vertex Pharmaceuticals (VRTX) is rated as a "Strong Buy" due to robust revenue growth and multiple expansion opportunities ...

Chameleons have spiral optic nerves, CT scans and 3D modelling reveal. The discovery explains how the lizards can literally ...

While the launches of Journavx and Casgevy have started to build steam, “investors may not be inclined to look past the clear ...